This guidance emphasises the potential of NGS methods in mitigating safety risks associated with therapies incorporating ...

A study from Columbia University Mailman School of Public Health reports a major advance in understanding how interactions ...

A team of researchers spent years watching their quantum circuits fail before one finally worked. In early 2025, scientists ...

Metagenomi Therapeutics, Inc. (Nasdaq: MGX) (the “Company”), an in vivo genome editing company capitalizing on its proprietary technologies to create curative genetic medicines for patients, today ...

To many, the genome is a puzzle—a many-sided puzzle whose meaning stretches across your life, your children's, and your family's. To many, the genome is a puzzle—a many-sided puzzle whose meaning ...

Researchers at the University of Zurich have analyzed the genome of bacteria living in Lake Zurich to conclude that microbes ...

The promise of genome editing to help understand human diseases and create new therapies is vast, but technological limitations have limited advancement of the field. While existing editing ...

Latin American people are represented in fewer than 4% of genetic epidemiological studies around the world. When they are included, they're often lumped together as one group, despite the rich ...

EPFL scientists have discovered that a simple shape change in mitochondria helps cells evenly distribute their mitochondrial ...

A research team has uncovered the genomic basis behind why some vine tea varieties accumulate far more dihydromyricetin than others.

Explore the decades-long journey to map the full human genome, from early breakthroughs to the first complete, gapless DNA ...

A study from Columbia University  reports a major advance in understanding how interactions between human and viral genomes shape disease risk. The research found that variations in the Epstein–Barr ...